[Federal Register Volume 76, Number 52 (Thursday, March 17, 2011)]
[Notices]
[Page 14689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-6165]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated November 19, 2010, and published in the Federal 
Register on December 3, 2010, 75 FR 75496, Meridian Medical 
Technologies, 2555 Hermelin Drive, St. Louis, Missouri 63144, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of Morphine (9300), a basic class of 
controlled substance listed in schedule II.
    The company manufactures a product containing morphine in the 
United States. The company exports this product to customers around the 
world, including in Europe. The company has been asked to ensure that 
its product sold to European customers meets standards established by 
the European Pharmacopeia, which is administered by the Directorate for 
the Quality of Medicines (EDQM). In order to ensure that its product 
will meet European specifications, the company seeks to import morphine 
supplied by EDQM to use as reference standards. This is the sole 
purpose for which the company will be authorized by DEA to import 
morphine.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Meridian Medical Technologies to import the basic class 
of controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. DEA has investigated Meridian 
Medical Technologies to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, 
the above named company is granted registration as an importer of the 
basic class of controlled substance listed.

    Dated: March 9, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-6165 Filed 3-16-11; 8:45 am]
BILLING CODE 4410-09-P